Headlines:
Search for Healthcare Articles by

Cardiology Therapies


< Previous   Page 3 of 35   Next >
Search returned 349 items.
sort by:   Title | Author | Publication | Date

Heart Pump: FDA Approves Use of Temporary Pump to Assist Heart's Right Side

Approval is a first for certain critically ill patients
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01898.html

FDA Analysis Shows Cholesterol Lowering Medications Do Not Increase the Risk of "Lou Gehrig's Disease"

Agency recommends no change in prescribing and use of statins
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01892.html

Safety Alert: Hospitals Need Strict Heparin Rules

A regulatory group told hospitals Wednesday to adopt strict measures to prevent errors involving blood thinners including heparin...
http://www.foxnews.com/story/0,2933,426901,00.html

VIDEO: Angioplasty with Stent Placement

Health Storm Center: Dr. Manny explores the first choice for treating a heart attack
http://www.foxnews.com/video/index.html?playerId=videolandingpage&streamingForm

VIDEO: Device aids congestive heart failure patients

http://www.msnbc.msn.com/id/21134540/vp/26544500#26544500

FDA Approves Software Update that Identifies Potential Defibrillator Lead Fractures

The new software package will alert both patients and physicians of a potential lead fracture. This will enable early intervention and lower the risk of serious complications.
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01878.html

VIDEO: Coronary Artery Disease-No#1 killer in the U.S.

http://video.syndication.msn.com/v/Legacy.aspx?mk=en-ap&g=6fbc417b-26cd-4edf-8b

FDA: Heart drug combo may harm muscles

FDA warns of rare injury from taking cholesterol and anti-arrhythmia pills
http://www.msnbc.msn.com/id/26093009/

European Drug Watchdog Supports New Pill by Bayer

Bayer&8217;s experimental anticoagulant Xarelto, its biggest new drug hope, has been recommended for approval by the European Medicines Agency.
http://www.nytimes.com/2008/07/26/business/26drug.html?ref=health

Trial Intensifies Concerns About Safety of Vytorin

In a clinical trial, the cholesterol-lowering drug Vytorin did not help people with heart-valve disease avoid further heart problems but did appear to increase their risk of cancer, scientists reported Monday.
http://www.nytimes.com/2008/07/22/business/22drug.html?ref=health
< Previous   Page 3 of 35   Next >
Search returned 349 items.
Sponsored Links
Clinical Researchers, others from
subscriber lists and assoc's.
www.biotechmedia.com
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com